Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Grenier, FR

Alfred Grenier, Saint-Cyr Au Mont D'Or FR

Patent application numberDescriptionPublished
20110281729SYNTHETIC COMPOUNDS USEFUL AS NODULATION AGENTS OF LEGUMINOUS PLANTS AND PREPARATION PROCESSES THEREOF - The present invention relates to synthetic compounds that are active on plants, especially as legume nodulation factors, and also as plant growth stimulators, and to methods for preparing such compounds, which are of formula (I).11-17-2011

Annie Grenier, Chassieu FR

Patent application numberDescriptionPublished
20100263089USE OF POLYPEPTIDE DERIVED FROM A PA1B LEGUME ALBUMEN AS INSECTICIDE - The invention concerns the use of a polypeptide derived from a PAlb legume albumen as insecticide, particularly for protecting cereal grains against insect pests.10-14-2010

Arnaud Grenier, Steinbrunn Ie Haut FR

Patent application numberDescriptionPublished
20100217176METERED GEL DISPENSER - The invention relates to a dermal flowable-composition dispenser that includes a body for retaining a supply of the composition, an application portion having an application surface, and a conduit connecting the supply chamber with the application surface for facilitating the reproducible delivery of a predetermined dose of the composition to the application surface. The application surface includes a concave application surface and a front side having an upper rim enclosing the application surface and forming a depression that has a volume that is greater than or equal to the volume of the predetermine dose. Also, the application surface is configured and dimensioned such it can receive the patient's skin to allow for removal of the predetermined dose of the composition, and wherein the concave application surface is shaped such that the entire application surface contacts the patient's skin when the application surface is pressed thereagainst.08-26-2010

Arnaud Grenier, Steinbrunn Le Haut FR

Patent application numberDescriptionPublished
20080233179TRANSDERMAL COMPOSITION HAVING ENHANCED COLOR STABILITY - A pharmaceutical composition for transdermal or transmucosal delivery of a pharmaceutical agent effective to treat a neurological disorder such as Parkinson's disease is disclosed. The composition contains an antioxidant, which provides color and chemical stability of the pharmaceutical agent. The antioxidant may also provide enhanced skin permeability of the agent. 09-25-2008
20080260842PERMEATION ENHANCING COMPOSITIONS FOR ANTICHOLINERGIC AGENTS - A transdermal or topical skin-friendly composition including anticholinergic agents, such as oxybutynin, a urea-containing compound and a carrier system. A method is disclosed for treating a subject for urinary incontinence while reducing the incidences of peak concentrations of drug and undesirable side effects associated with oral anticholinergics.10-23-2008
20090069364PHARMACEUTICAL COMPOSITIONS OF 5-ALPHA-REDUCTASE INHIBITORS AND METHODS OF USE THEREOF - Non-occlusive compositions for transdermal delivery of 5-alpha-reductase inhibitors, and more particularly finasteride or dutasteride or pharmaceutically acceptable salts or derivatives thereof, and methods of making same. The composition may, for example, be a gel suitable for transdermal or transmucosal applications. The compositions of the present invention typically include a mixture of water and alcohol, and a solvent system having a mono alkyl ether of diethylene glycol and a glycol present in specified ratios and in specific amounts, wherein the pH of the gel is usually between about pH 4.5 and about pH 8. The compositions may include further components, for example, the hydroalcoholic vehicle may further include additional penetration enhancer(s), buffering agent(s), antioxidant(s), stabilizer(s) and/or gelling agent(s). Also, a method for the sustained delivery of 5-alpha-reductase inhibitors to treat a variety of conditions and disorders.03-12-2009
20100216880TRANSDERMAL COMPOSITIONS FOR ANTICHOLINERGIC AGENTS - The present invention relates generally to compositions or formulations for transdermal or transmucosal administration of anticholinergic agents such as oxybutynin. The invention utilizes a novel delivery vehicle and is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters. A method is disclosed for treating a subject for urinary incontinence with these formulations while reducing the incidences of peak concentrations of drug and undesirable side effects associated with oral anticholinergics.08-26-2010
20110195114TRANSDERMAL DELIVERY SYSTEMS FOR ACTIVE AGENTS - A delivery vehicle for topical pharmaceutical formulations that include a C2 to C4 alkanol, a polyalcohol, and a monoalkyl ether of diethylene glycol present in relative amounts sufficient to provide permeation enhancement of an active agent through mammalian dermal or mucosal surfaces. Preferably, the delivery vehicle as well as the formulations that contain it are substantially free of long-chain fatty alcohols, long-chain fatty acids and long-chain fatty esters in order to avoid potential undesirable odor and irritation effects caused by such compounds during use of the formulation. Without these additives, use of the formulations is facilitated and patient compliance is greater08-11-2011
20110245215TRANSDERMAL DELIVERY SYSTEMS FOR ACTIVE AGENTS - A formulation for transdermal or transmucosal administration of an active agent. The formulation includes an active agent and a delivery vehicle comprising a C10-06-2011
20110257141TRANSDERMAL PHARMACEUTICAL FORMULATION FOR MINIMIZING SKIN RESIDUES - This invention relates to novel transdermal or transmucosal pharmaceutical formulation having an active agent of testosterone which reduces the occurrences of contamination of other individuals and the transference to clothing of the user. The solvent system of the formulation includes a monoalkylether of diethylene glycol and a glycol present in specified ratios, and a mixture of water and alcohol. The invention also relates to a method for inhibiting or delaying crystallization of the active agent in a pharmaceutical formulation.10-20-2011

Patent applications by Arnaud Grenier, Steinbrunn Le Haut FR

Benjamin Grenier, Saint-Paul-En-Jarez FR

Patent application numberDescriptionPublished
20100307412HOT-DIP GALVANIZING INSTALLATION FOR STEEL STRIP - An installation for the hardened galvanization of a continuously-moving rolled steel strip, includes a coating tank receiving a liquid metal mixture containing, for example, zinc and aluminum to be deposited on the strip which is immersed in the mixture. The liquid mixture is permanently circulated between the coating tank and a preparation device, in which the temperature of the liquid mixture is deliberately lowered in order to reduce an iron solubility threshold and is sufficiently high for initiating fusion of at least one ingot containing a zinc-aluminum Zn—Al alloy in a so-called fusion zone of the preparation device, in an amount necessary to compensate for the liquid mixture used for deposition on the strip. The installation includes a loop for circulating the liquid mixture that is thermally optimized.12-09-2010
20100323095METHOD FOR THE HARDENED GALVANIZATION OF A STEEL STRIP - A method produces a hardened galvanization of a continuously-running rolled steel strip. The strip is immersed in a coating tank containing a bath of a liquid metal mixture, e.g. zinc and aluminum, to be deposited on the strip, and permanently circulated between the coating tank and a preparation device. The temperature of the liquid mixture is deliberately lowered in order to reduce the iron solubility threshold and sufficiently high for initiating, in the preparation device, the fusion of at least one Zn—Al ingot in an amount necessary for compensating for the liquid mixture used for deposition on the strip. The device is implemented so that the circuit for circulating the liquid mixture is thermally optimized.12-23-2010
20110177258METHOD AND DEVICE FOR WIPING LIQUID COATING METAL AT THE OUTLET OF A TEMPERING METAL COATING TANK - A method and device disclose how to drain a liquid coating metal from the two sides of a running steel strip. The method transfers a strip coated with a liquid coating metal, as it runs at the tank outlet, from a region not subjected to a magnetic field to another region subjected to a static magnetic field generated between the poles of magnetic members arranged opposite each other on either side of the strip and having field lines, or at least a main shell of the field lines, intersecting with the strip over at least one minimum longitudinal extent so that the liquid coating metal is correlatively subjected to a magnetic field variation generating on the liquid metal a force opposite to the running direction. Due to the low field variation, this magnetic braking effect generates little Foucault current in the strip.07-21-2011
20110222057METHOD AND DEVICE FOR MEASURING A CHEMICAL COMPOSITION OF A LIQUID METAL SUITABLE FOR COATING A STEEL STRIP - A method and a device measure a chemical composition of a liquid metal suitable for coating a steel strip. The method measures a chemical composition of a liquid metal suitable for coating a steel strip for which the liquid metal is formed continuously in a first cavity, and the composition of the liquid metal is measured on a direct measurement surface thereof, for which a specimen of the liquid metal reaching the measurement surface is heated to a chosen temperature so as to isolate principally iron-based impurities from the measurement surface. Several embodiments of devices suitable for implementing the method are also presented.09-15-2011
20110265604METHOD AND DEVICE FOR CONTROLLING THE INTRODUCTION OF SEVERAL METALS INTO A CAVITY DESIGNED TO MELT SAID METALS - A method and a device control the introduction of several metals into a cavity configured to melt the metals in the form of ingots. In particular, the method is configured to control the introduction of several metals into a cavity for melting the metals so as to dip-coat a steel strip with the metals in liquid metal form. Whereby a first metal is introduced in the form of at least a first ingot having a high content of the first metal and a second metal is introduced in the form of at least a second ingot formed as an alloy of the first metal and the second metal. The second metal content of the second ingot is chosen from a range of significant contents for ensuring an intended overall flow rate for combined melting of the ingots, the range of significant contents being chosen in a limited interval of sequentially increasing values so as to minimize differences between melting points of the ingots.11-03-2011

Celine Grenier, Petit Couronne FR

Patent application numberDescriptionPublished
20100179255METHOD OF PREPARING ASPHALT - A method of preparing asphalt, comprising a step of combining a bitumen composition with aggregate, is disclosed. The bitumen composition comprises greater than 75 wt % bitumen and between 0.005 and 0.5 wt % polyacrylamide.07-15-2010

Denis Grenier, Lyon FR

Patent application numberDescriptionPublished
20100213936MRI SPATIAL ENCODING USING HYPERCOMPLEX NUMBERS - The disclosure relates to a method of processing a complex signal comprising acquisition of a signal in the form of complex numbers; determination on the basis of the complex signal acquired of the associated hypercomplex components, said components corresponding to at least derivatives with respect to time of the phase of the complex signal acquired; processing of the hypercomplex signal thus determined in such a way that the signal resulting from the processing comprises a greater number of components than the number of components of the signal acquired.08-26-2010

Dominique Grenier, Hellemmes FR

Patent application numberDescriptionPublished
20100009396METHOD FOR MEASURING THE CONCENTRATION OF ACTIVATED FACTOR VII (FVIIA) IN A SAMPLE - The present application concerns a method for the in vitro or ex-vivo measurement of the FVIIa concentration of a sample, comprising the steps consisting of: 01-14-2010
20110097754METHOD FOR MEASURING ACTIVATED FACTOR VII LEVEL IN A SAMPLE - The present disclosure relates to a method for measuring the activated factor VII level in a sample to be tested, including the steps of: a) mixing the test sample with a plasma free of factor VII (FVII) and free of at least another factor selected from among factor VIII (FVIII), factor IX (FIX), and factor XI (FXI), the test sample+plasma having a final FVII+FVIIa concentration of 10 pM to 80 pM; b) adding initiating components from the thrombin generation reaction; c) obtaining a thrombogram when carrying out a thrombin generation test (TGT) on the mixture from step b); d) comparing at least one of the thrombogram parameters from step c) with a homologous parameter obtained from standard thrombograms established on the basis of standard samples, the activated factor VII level of which is known and varies with each standard sample; e) deducing, from step d), an activated factor VII level measurement in the test sample.04-28-2011

Gilbert Grenier, Annonay FR

Patent application numberDescriptionPublished
20090100975Rotary cutter, and anvil roll for rotary cutting apparatus - A rotary cutting apparatus includes a rotary cutter and a cooperating anvil roll, each including a center arbour, a peripheral sleeve, and an intermediate sleeve disposed radially between the peripheral sleeve and the arbour. The intermediate sleeve of either the rotary cutter on the anvil roll, or both can be formed of a material for vibration damping, thermal insulation, thermal conduction, weight increase and/or weight reduction.04-23-2009
20090249931Rotary cutter drum and a rotary cutter unit with such a rotary cutter dum - A rotary cutter drum includes a cutter portion formed of a multiphase material and includes first and second substantially cylindrical, radially outwardly exposed surfaces, and a knife member formed of one piece with the exposed surfaces and arranged to axially separate the first and second surfaces from one another. The knife member protrudes by a distance in the range of 1 to 5 mm radially outwardly beyond a smallest diameter portion of the first and second exposed surfaces. The knife member includes two sides terminating at respective ones of the first and second exposed surfaces.10-08-2009

Jean-Claude Grenier, Cadaujac FR

Patent application numberDescriptionPublished
20100092829GAS ELECTRODE, METHOD FOR MAKING THE SAME AND USES THEREOF - A gas electrode includes a plurality of stacked layers (04-15-2010

Pascal Grenier, Kappeien FR

Patent application numberDescriptionPublished
20100092557Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid Analgesic - A dosage form adapted for twice-a-day administration comprising a naproxen species in an immediate release phase and an opioid analgesic in a sustained release phase. The dosage form is useful in the treatment of pain.04-15-2010